| Name | Title | Contact Details |
|---|
Watkins is a company that produces natural products, including gourmet flavors, and has been in operation since 1868.
Royal Cup, Inc. is a major importer, roaster and distributor of premium and specialty coffees and teas to foodservice companies, business offices, convenience stores, chain restaurants and hotels located throughout the United States and the Caribbean. Established in 1896, Royal Cup remains a family-owned company dedicated to providing unparalleled service for each customer.
We work closely with local farms and restaurants committed to local sustainability to bring the freshest produce to businesses like yours. Connect today!
With more than 2,000 employees and net sales of more than $1 billion, Sargento Foods is a family-owned, privately-held company that has been an innovator in cheese for more than 65 years. Founded in 1953 in Plymouth, Wisconsin, Sargento created the world`s first successful pre-packaged sliced and shredded natural cheeses. Today, Sargento Foods is still based in Wisconsin, where they manufacture and market amazing shredded, sliced and snack natural cheese products, as well as ingredients and sauces. Company leadership lives to serve local communities and employees who are part of the Sargento Family.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.